NCT04977791View on ClinicalTrials.gov

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

July 21, 2016

Primary Completion Date

December 1, 2026

Study Completion Date

December 31, 2028

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Anti-PD-1/PD-L1 monoclonal antibody

Observe a situation before and after immunotherapy

Trial Locations (1)

Unknown

RECRUITING

Xiaomin Niu, Shanghai

All Listed Sponsors

lead

Shanghai Chest Hospital

OTHER